Delivery Order SPE2DB20D3103-SPE2DB23FP2E0

Award Date 8/2/23
Potential Completion Date 8/3/23
Potential Value $956
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $5,696.44 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4562201052 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order has a period of performance from September 16, 2023 through September 18, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the United States Department of...
The Defense Logistics Agency awarded a $3,855.61 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561836722 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order is to deliver the specified pharmaceutical product and has a period of performance from August 16, 2023 through August 17, 2023. As the DLA supports the procurement of medical supplies and equipment for the...
The Defense Logistics Agency awarded a $2,127 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561419851 XYOSTED 75 MG/0.5 ML auto-injectors. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two-day period in early July 2023. No set-aside...
The Defense Logistics Agency awarded a $1,831 firm fixed price delivery order to Amerisourcebergen Drug Corporation for XYOSTED 100 MG/0.5 ML auto-injectors. The delivery order was issued against an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 26, 2023. No subcontractors or set-aside designations were identified. This order...
The Defense Logistics Agency awarded a $251,420 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4562108517, identified as XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The firm fixed-price contract will be performed in Conshohocken, Pennsylvania over a one-day period from September 10-11, 2023. As a major component of the Department of Defense supply chain, the DLA supports military readiness by procuring critical medical supplies for servicemembers. No set-aside...
The Defense Logistics Agency Troop Support Medical awarded a $350,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561853520 XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 17, 2023 through August 18, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support in procurement and supply chain...
The Defense Logistics Agency awarded a $251,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 10-11, 2023. No subcontractors or set aside...
The Defense Logistics Agency Troop Support Medical awarded a $251,420 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561598089 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 25, 2023 through July 26, 2023. As the prime contractor, Amerisourcebergen will likely fulfill the order for these medical injection devices...
The Defense Logistics Agency Troop Support Medical awarded a $1,087 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561949810 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. Performance will take place in Conshohocken, Pennsylvania from August 25-28, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring medical supplies and pharmaceuticals to support military treatment facilities worldwide. No set aside...
The Defense Logistics Agency Troop Support Medical awarded a $802,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561888736 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on August 21, 2023 through August 22, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP2E0
    Delivery Order

The Defense Logistics Agency awarded a $955 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561679713 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. No set aside provisions or subcontractors were identified. This order continues DLA's procurement of specialty drugs to meet treatment needs for all branches of the military.

Generated 12/23/23, 1:02 PM